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DNA methylation is an important molecular-level phenotype that links genotypes and complex disease traits. Previous
studies have found local correlation between genetic variants and DNA methylation levels (cis-meQTLs). However,
general mechanisms underlying cis-meQTLs are unclear. We conducted a cis-meQTL analysis of the Genetics of Lipid
Lowering Drugs and Diet Network data (n = 593). We found that over 80% of genetic variants at CpG sites (meSNPs) are
meQTL loci (P value < 10 −9), and meSNPs account for over two thirds of the strongest meQTL signals (P value < 10 −200).
Beyond direct effects on the methylation of the meSNP site, the CpG-disrupting allele of meSNPs were associated with
lowered methylation of CpG sites located within 45 bp. The effect of meSNPs extends to as far as 10 kb and can contribute
to the observed meQTL signals in the surrounding region, likely through correlated methylation patterns and linkage
disequilibrium. Therefore, meSNPs are behind a large portion of observed meQTL signals and play a crucial role in the
biological process linking genetic variation to epigenetic changes.

DNA methylation plays an important role in gene regulation.
As such, it is an important intermediate molecular phenotype
that links genotypes and other macro-level phenotypes and may
contribute to the missing heritability.1 Despite their prominent
physiologic role, the genetic determinants of DNA methylation
patterns are poorly understood. There is evidence of correlation
between genetic variation at specific loci and the quantitative trait
of DNA methylation.2-5 Additionally, prior studies6,7 revealed
that genetic variants at CpG sites (meSNPs) are likely to disrupt the substrate of methylation reactions and thus drastically
change the methylation status at a single CpG site. However, it
is unclear if meSNPs represent a major class of methylation-associated loci (meQTLs). Moreover, it is unclear if meSNPs modulate the methylation status of nearby CpG sites. Most existing
meQTL studies2-5 are based on relatively small-sized samples and
low-resolution methylation microarrays, wherein meSNPs are
sparsely represented. Additionally, current practices of meQTL
analysis typically exclude probes that contain sequence variants
to limit misclassification due to alterations in probe hybridization.2,3 Recently, we generated high-resolution genotyping and
epigenetic data from the Genetics of Lipid Lowering Drugs
and Diet Network (GOLDN),8 yielding a considerable amount
of meSNPs with information on both genotype and methylation status. These data enabled us to investigate the impact of
meSNPs on the methylation status of the CpG site harboring the
SNP, as well as on surrounding CpG sites.

We used CD4+ T-cells harvested from frozen buffy coat samples isolated from peripheral blood for methylation measurement.
We used CD4+ T-cells simply due to their abundance and physiological role in the immune response. While that ensures higher
validity of findings, our results may not be generalizable to other
cell populations. After genotype imputation and quality control
(see Supplemental Methods), we had data for 461 281 CpGs of n
= 593 GOLDN participants. All participants had previously been
genotyped at 906 600 loci using the Affymetrix Genome-Wide
Human SNP Array 6.0, as described in prior publications.9,10
MACH software (Version 1.0.16) was used to impute nongenotyped SNPs using HapMap Phase II (release 22, Human
Genome build 36, hg18) as a reference, resulting genotypes of
2 529 001 SNPs.
We first performed a genome-wide cis-meQTL analysis of
GOLDN data. We restricted the analysis to SNP/CpG site pairs
within 20 kb of each other, and removed the pairs in which the
SNP was located on the methylation probe as described below,
yielding 12 347 772 pairs for the final analysis. We used linear
mixed models, fit using the lmekin function of the Kinship package in R,11 to regress the methylation level (β value) of a CpG site
on the genetic variant at a SNP site, adjusting for covariates (age,
sex, and recruitment center) as fixed effects and family structure as a random effect. Adjusting top principal components of
phenotype matrix is an effective approach to reduce experimental artifacts and enhance power for gene expression quantitative
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trait analysis.12,13 Therefore, we adjusted for the top four principal
components as the proportion of explained variance in methylation drops off sharply after the fourth principal component. We
identified 465 649 cis-meQTL signals, defined as any SNP/CpG
site pair within 20 kb distance of each other that reached the
nominal P-value cutoff of 10−9. We used the significant association of random SNP/CpG site pairs as an upper bound of false
discoveries, a strategy used in expression QTL analysis.12 While
that approach overestimates the true false discovery rate (FDR)
due to ignoring any potential true trans-meQTLs, it is easier to
compute and preserve all family structure and covariates. Using
130 million pairs, we estimated that the nominal P value of 10−9
as equivalent to the FDR of 0.000 004, and the nominal P value
of 10−200 as FDR < 7.7 × 10 −9 (no random pairs with P < 10 −200).
As expected, these Pvalues far exceed the cutoffs used in previous
reports2-5 due to the high density of the M450K chip.
Although the M450K chip is not designed for profiling methylation levels at CpG sites harboring SNPs, valid methylation
measurements can nevertheless be obtained through careful
analysis. The M450K chip is known to have a “probe effect,”
i.e., the SNP/CpG site pair with the SNP on the probe may be
enriched for meQTLs. While Illumina recommends caution for
the probe effect when the SNP is within 10 bp of the interrogated
CpG site, we observed that the probe effect is present throughout the entire length of the 50 bp probe (Fig. S2). Therefore,
we removed all pairs with SNPs on the probe from this analysis.
However, it is important to note that, among the two chemistries in the M450K platform—Infinium I and Infinium II—only
Infinium I measurements, whose probe covers the entire CpG
dinucleotide, are subject to the probe effects of SNPs at the CpG
site itself. For the 1 bp extension of Infinium II chemistry, position 0 on a forward probe and position 1 on a reverse probe do
not hybridize to interrogated DNA and thus still provide valid
methylation measurements (see Supplemental Methods). After
excluding probes that matched to non-unique positions in the
hg19 genome as well as the 95 sites located on Infinium I probes,
we first investigated these 812 meSNPs for which both methylation level and genotype were directly observed or imputed. See
Table S1 for a complete list of these meSNPs.
Many of the most statistically significant meQTLs were colocalized to the 812 meSNPs (Fig. 1). 85% of meSNPs interrogated by forward strand probes and 92% by reverse strand probes
were cis-meQTLs (Fig. 1). These SNPs were strongly negatively
associated with the methylation of the CpG site (Table 1). CismeQTL signals remained strong at 1–3 bp away from the CpG
site (20–45%), but sharply decreased to < 0% for most sites >3 bp
away from the CpG site. The signal attenuated to approximately
5% of pairs separated by the distance of 1000 bp and 3% for
pairs at 20 000 bp, still well above the 0.0003% for random pairs
in the entire genome. Interestingly, we observed that pairs with
SNPs on the probe do have inflated meQTL signals (Fig. S2).
Absence of a significant meQTL signal at meSNPs was mainly
due to the methylation being already depleted for the CpG allele
or to very low genetic variation. Therefore, we conclude that
meSNPs indeed disrupt the methylation and that the M450K
chip provides accurate measurement of that phenomenon.
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We subsequently investigated the potential impact of meSNPs
on the methylation status of nearby CpG sites, located within
100 bp. It is notable that the M450K chip only directly measures
the methylation status at CpG sites of the reference genome, and
thus only SNPs that disrupting CpG sites are directly observable. To study the potential effect of all CpG-gain SNPs to
nearby CpG sites, we conducted a bioinformatics annotation
of all SNPs in the GOLDN and the 1000 Genomes Project
phase 1 release. All SNPs were classified into four categories in
terms of changing CpG sites on the reference genome: CpGloss, which eliminates a CpG site; CpG-gain, which creates a
CpG site; CpG-shift, which represents a variant between CCG
and CGG that shifts the position of a CpG site by 1 bp; and
CpG-irrelevant. CpG-loss and CpG-gain SNPs are only defined
relative to the reference genome; both CpG-loss and CpG-gain
have an allele that disrupts the substrate of methylation and thus
are likely to be meQTLs. All 812 meSNPs represented on the
M450K chip and were successfully genotyped in GOLDN are
either CpG-loss (803, 99%) or CpG-shift (9, 1%). We scanned
all 39 million SNPs from the 1000 Genomes Project phase 1
release and all 2.5 million SNPs in the GOLDN imputed variant set, resulting in the classification of SNPs as shown in Figure
S3. Overall, we found that 14% of GOLDN SNPs are CpG-loss
and 14% are CpG-gain. Similar proportions were observed in
the 1000 Genomes Project Phase 1 SNPs (Fig. S3).
Although the methylation measurements at CpG-gain SNPs
and many of the CpG-loss SNPs are not directly observed,
we reasoned that they likely follow the same pattern as the
812 CpG-loss SNPs discussed above. To investigate the effect
of meSNPs to the methylation at immediate nearby sites, we
looked for meQTLs (P < 10 −9) between 701 CpG-gain or 861
CpG-loss SNPs with allele frequency between 5% and 95%
represented in the GOLDN genotype set and CpG sites within
100 bp (but not at the SNP directly) with M450K measurements in Infinium II chemistry, and found 1562 such pairs.
Through a linear regression of the effect sizes of these meQTL
and the distance between the SNP-CpG pairs, we found that,
for each CpG-disrupting allele, the methylation of CpG sites at
very close distance is also lowered for about 2% (P value = 3 ×
10 −11 for the intersect), but the effect is diminishes to flat and
even a slight elevation beyond 60 bp (P value = 4.0 × 10 −10 for
the slope) (Fig. 2). This result suggests that a CpG-changing
SNP can affect not only the methylation status of its own CpG
site, but also the methylation patterns surrounding it at very
close distance. However, while this may point to an interesting
methylation regulation mechanism, additional investigations
are warranted to rule out potential technical artifacts such as
local hybridization competition.
Finally, we investigated whether meSNPs may explain
meQTL signals at surrounding sites located within 10 kb. Not
all meQTL signals are due to independent association signals.
In particular, we observe that meQTL signals show a prominent
correlation pattern (Fig. 2B). We therefore hypothesize that,
in the neighborhood of a meSNP with genotype X and CpG
methylation Y, the meQTL signal between genotype X' and
CpG methylation Y is due to their respective correlations to the
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Table 1. Summary of 812 cis-meQTLs at meSNPs probed by Infinium II chemistry
Strand

Position within CpG

Ref

Alt

Count

Mean −log10P val

Mean effect size β

%meQTL*

F

0

C

A

6

102.0

−0.207

83.33%

F

0

C

G

11

95.2

0.151

90.91%

F

0

C

T

79

108.3

−0.229

84.81%

R

1

G

A

606

115.4

−0.216

92.41%

R

1

G

C

48

74.5

0.111

87.50%

R

1

G

T

62

103.1

−0.217

88.71%

*% of pairs with P < 10 −9. See Supplemental Methods for an interpretation of the effect sizes.

meSNP pair X and Y: X' to X by linkage disequilibrium, Y' to
Y by methylation correlation. Unlike standard mediation analyses, we are not claiming a chain of causative links, but rather
to test if the associations X' to Y' and X to Y are independent.
Instead of running a full mediation analysis,14 we conducted
a partial mediation analysis, i.e., the conditional regression of
Y' to X' given Y, in addition to the pairwise meQTL analysis.
If they are truly independent associations, regressing Y' to X'
conditional on Y should not eliminate the significant meQTL
association between Y' and X'.

804

We found a considerable attenuation of meQTL signals surrounding meSNPs (Fig. 2C vs. B). In the 10 kb neighborhood of
812 observed meSNPs, the total numbers of meQTLs decreased
by 32.8%, from 8017 to 5384 after the adjustment. Given the
genome-wide distribution of meSNPs, most of which are not
directly observed on the M450K chip, we estimate that meQTLs
at meSNPs may explain a large portion of observed cis-meQTL
signals.
Overall, our analysis provides the first genome-wide profiling of methylation changes at and surrounding SNPs. These
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Figure 1. meSNPs are enriched for the most significant meQTL signals. (A) The percent of CpG sites that are meSNP, within 20 kb neighborhood of a
meSNP (“neighborhood”), or “all others.” For each CpG site, the measure of its meQTL signals is the maximum of −log10(P value) of its SNP/CpG pairs.
For each bin of −log10(P value), we plotted the percent of each type of CpG sites. (B) Proportion of SNP/CpG site pairs with meQTL signal, defined as P
value < 10 −9, stratified by distance. 96 meSNPs at the position 0 and 716 meSNPs at position 1 are represented. On average, 138 non meSNP pairs per
position are within position <50 bp, and 283 pairs per position between 50 and 100 bp, reflecting the change in effect due to filtering out the “probe
effect.”

meSNPs contribute to the strongest methylation QTL signals
as they disrupt the methylation status at CpG sites. Moreover,
meSNPs also modulate methylation status at nearby CpG sites
and a large proportion of variability in DNA methylation can
be explained by genetic variation at the CpG site itself. Our data
suggest a potential biological mechanism underlying associations
between common genetic variants, epigenetic processes, and

www.landesbioscience.com

disease phenotypes. We conclude that meSNPs may be a crucial
class of variants to be considered in interpretation of genomic and
epigenomic association results.
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Figure 2. Effect of meSNPs on methylation at nearby CpG sites. (A) Near-range effect of meSNPs. For 1,562 CpG-changing (including CpG-loss and
CpG-gain) SNPs that have significant meQTL (P value < 10 −9) to a CpG site within 100 bp, we plot their SNP-CpG distance (X-coordinate) vs. their meQTL
effect sizes (Y-coordinate). Both CpG-loss and CpG-gain SNP genotypes are oriented such that the CpG-carrying allele is coded as 0 and the non-CpGcarrying allele is coded as 1. (B and C) Effect of meSNP beyond immediate neighborhood. We plotted the distribution of cis-meQTL signals surrounding 812 meSNPs in the GOLDN data, before (B) and after (C) adjusting for meSNPs. The center is the location of the meSNPs. The X-axis represents the
relative position of the SNP to the central meSNPs, organized into 101 equal-sized bins, each covering 198 bp. The Y-axis represents similar bins for the
relative position of the CpG to the meSNPs. Color of the heatmap represents the number of meQTLs found at the distance bin.
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